Changes in cholinergic nerve cells were first reported in Alzheimer's disease in 1976,1 with substantial losses of the enzymes choline acetyl transferase (CAT) and acetyl cholinesterase being observed. Since then, these findings have been amply confirmed in both biopsy23 and necropsy4-10 brain tissue, and the reduction in CAT activity correlated with degree of histological change and mental status of the patient.311 Although these changes have been widely thought2 4 9 to represent a selective involvement of cholinergic pathways in Alzheimer's disease, therapeutic trials12-'9 aimed at making good this deficiency have not demonstrated any consistent or long-lasting improvements in mental ability, following such treatments; this suggests that alterations in this kind of nerve cell may only be part of a more widespread degenerative process.
Recent biochemical studies20-25 have indicated that deficiencies in the noradrenaline containing nerve cells of the CNS may occur also, in Alzheimer's disease but not in that dementia associated with cerebrovascular alterations.21 22 Therefore, in this report, the involvement (in dementia) of noradrenergic nerve cells is morphometrically investigated, through microscopic counting of cell number, together with histometric evaluation of their capacity to produce the proteins appropriate to physiological function. The nerve cells examined are the melanin pigmented cells of the locus caeruleus and dorsal motor nucleus of the vagus nerve, on which this neurotransmitter system is principally based.
Materials and methods
Brains were obtained at necropsy from 19 patients (table 1) who, in life, showed a profound progressive dementia with no localising neurological signs. Neuropathological examination revealed numerous senile plaques and nerve cells containing neurofibrillary tangles, in cerebral cortex, hippocampus and amygdala, with no significant amount of vascular disease or ischaemic change. A diagnosis of Alzheimer's disease was made. Another eight patients (table 1) , whose mental deterioration was clearly related to extensive macro-infarction and micro-infarction of cerebral cortex and basal ganglia, were classed as cases of multi-infarct dementia. Twenty-one patients, none of whom had suffered from overt neurological or psychiatric illness, and in which there were no significant histological findings other than minimal amounts of cerebral softening or Alzheimer type changes, or both, were controls (table 1) .
The cause of death was broadly similar in all three groups, being generally associated with a terminal respiratory illness or cardiac insufficiency. There were no The numbers of nucleolated nerve cells were also counted28 in the five Azure B stained 20 ,um sections from which the mean number per 20 /Lm section was determined for all three cell types. This kind of sampling has been shown28 to give quantitatively similar findings to those obtained by counting cells in every 10th section throughout the entire length of the locus. 29 In these and in adjacent 5 itm sections stained by conventional neuropathological methods, the general cytological features of the locus caeruleus and vagus nerve nucleus in age and dementia were detailed.
In seven patients (two Alzheimer, three multi-infarct and two controls) the brains were obtained after similar post mortem delay times, but all within 24 hours of death and these, prior to fixation, were sectioned down the mid-line having first removed the brain stem and cerebellum. The right half and brain stem were fixed in formalin and examined histologically whilst from the left side and cerebellum standard samples of frontal, temporal and occipital cortex, caudate nucleus, putamen, hippocampus, hypothalamus and cerebellar cortex were dissected and analysed21 for noradrenaline concentration which was expressed as Htg/gm brain tissue. Residual tissues were then fixed also for histological inspection.
Results
In the control and multi-infarct groups, the pigmented cells of the locus caeruleus were concentrated and evenly distributed (fig 1) . Occasional cells showed shrinkage of the cell body with reduction in nuclear and nucleolar sizes. In such contexts, possible roles of metal ions in the pathogenesis of Alzheimer's disease have been proposed with either deficiencies of zinc36 or accumulations of aluminium,37 leading to alterations in the efficiency of those enzymes concerned with DNA synthesis, repair and transcription. Alterations in these cellular mechanisms could lead to a cascade of metabolic changes in nerve cells, but particularly in relation to their ability to form new proteins,38 39 culminating in their widespread dysfunction and even eventually their death.
20"
Recently, there have been reports40-42 of trials of levodopa, in patients with Alzheimer's disease but without extrapyramidal signs where significant improvements in mental performance were made during treatment, over periods of 6-9 months which were lost during a drug free period, but subsequently regained on resumption of medication.40 41 Since the brain's dopamine system is essentially unaltered in Alzheimer's disease,' 9 20 21 43 it is therefore possible that beneficial effects of L-dopa on mental function may have arisen through preferential modulation (stimulation) of the noradrenaline system.
Further studies are needed to establish the time course of the degeneration of the noradrenaline pathways in Alzheimer's disease, and its relationship to the pattern of alterations in mental function, since it may be that an additional noradrenergic deficit is one reason as to why patients may not respond to cholinergic treatment alone.
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